Could COVID-19 Hold The Key To Cancer Treatment? Here's What Study Says

A new study led by Justin Stebbing at Anglia Ruskin University suggests that severe COVID-19 infections can produce specialized monocytes with anti-cancer properties. These cells, mimicked in lab experiments, successfully shrank tumors in mice, offering new insights into cancer treatment and the potential of immune response-based therapies.